NewslettersImmune Regulation News SLC38A2 and Glutamine Signaling in cDC1s Dictate Anti-Tumor Immunity By Laurisa Dohm - July 7, 2023 0 Researchers established glutamine as an intercellular metabolic checkpoint that dictated tumor–type-1 conventional dendritic cell crosstalk, and licensed their function in activating cytotoxic T cells. [Nature] Full ArticlePress Release